Survey of drug-resistant tuberculosis in northwestern Russia from 1984 through 1994

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 3, 1998, Pages 177-183

  Viljanen, M K ^a   Vyshnevskiy, B I ^b   Otten, T F ^b   Vyshnevskaya, E ^b   Marjamaki M ^a   Soini, H ^a   Laippala, P J ^c   Vasilyef, A V ^b  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b ST PETERSBURG RESEARCH INSTITUTE OF PHTHISIOPULMONOLOGY   (Russian Federation)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

Epidemiology; Resistance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ARTICLE; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; RECURRENCE RISK; RUSSIAN FEDERATION; TUBERCULOSIS;

EID: 0031748119     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01691114     Document Type: Article

References (26)

1. Centers for Disease Control: Tuberculosis morbidity - United States, 1992. Morbidity and Mortality Weekly Report (1993) 42:696-704.
2. Raviglione MC, Sudre P, Riedel HL, Spinaci S, Kochi A: Secular trends of tuberculosis in western Europe. Bulletin of the World Health Organization (1993) 71:297-306.
3. Raviglione MC, Rieder HL, Styblo K, Khomenko AG, Esteves K, Kochi A: Tuberculosis trends in eastern Europe and the former USSR. Tubercle and Lung Disease (1994) 75:400-416.
4. World Health Organization: Tuberculosis trends in central and eastern Europe and countries of the former USSR. Weekly Epidemiological Record (1995) 70:21-22.
5. Drobniewski F, Tayler E, Ignatenko N, Paul J, Connolly M, Nye P, Lyagoshina T, Besse C: Tuberculosis in Siberia: I. An epidemiological and microbiological assessment. Tubercle and Lung Disease (1966) 77:199-206.
6. Lavy A, Mates A: A 10 year survey on Mycobacterium tuberculosis isolates in Israel and their drug resistance. Israel Journal of Medical Sciences (1994) 30:805-810.
7. Wayne LG, Krasnow I: Preparation of tuberculosis susceptibility testing mediums by impregnated discs. American Journal of Pathology (1966) 45:769-771.
8. Gardner MJ, Altman DG: Statistics with confidence (book). British Medical Journal, London, 1989.
9. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GM, Dooley SW: The emergence of drug-resistant tuberculosis in New York City. New England Journal of Medicine (1993) 328:521-526.
10. Wellman AC, Rose DN: Tuberculosis susceptibility patterns, predictors of multidrug resistance, and implications for initial therapeutic regimens at a New York City hospital. Archives of Internal Medicine (1994) 154:2161-2167.
11. Borchardt J, Kirsten D, Jorres R, Kroeger C, Magnussen H: Drug-resistant tuberculosis in northern Germany: a retrospective hospital-based study of 1,055 patients from 1984 until 1993. European Respiratory Journal (1995) 8: 1076-1083.
12. Bouvet E: Multiresistant tuberculosis. Presse Medicale (1996) 25:393-398.
13. Hoffner SE: Mycobacterium tuberculosis; some data from Sweden, Estonia and Ethiopia. Scandinavian Journal of Infectious Diseases (1995) 98: 17-18.
14. Schaberg T, Gloger G, Reichert B, Mauch H, Lode H: Drug-resistant pulmonary tuberculosis in Berlin, Germany, 1987-1993. European Respiratory Journal (1995) 8:278-284.
15. Tala E, Viljanen MK: Mycobacterial infections in Finland. Scandinavian Journal of Infectious Diseases (1995) 98:7-8.
16. Barnes PF, Elhajj H, Preston-Martin S, Cave MD, Jones BE, Otaya M, Pogoda J, Eisenach KD: Transmission of tuberculosis among the urban homeless. Journal of the American Medical Association (1996) 275:305-307.
17. Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R: Tuberculosis screening in alcoholics and drug addicts. American Review of Respiratory Disease (1987) 136:1188-1192.
18. Pablos-Mendez A, Raviglione MC, Battan R, Ramos-Zuniga R: Drug resistant tuberculosis among the homeless in New York City. New York State Journal of Medicine (1990) 90:351-355.
19. Brudney K, Dobkin J: Resurgent tuberculosis in New York City. Human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. American Review of Respiratory Disease (1991) 144:745-749.
20. Morris JT, McAllister CK: Homeless individuals and drug-resistant tuberculosis in south Texas. Chest (1992) 102:802-804.
21. Friedman LN, Williams MT, Singh TP, Frieden TR: Tuberculosis, AIDS, and death among substance abusers on welfare in New York City. New England Journal of Medicine (1996) 334:828-833.
22. Drobniewski F, Tayler E, Ignatenko N, Paul J, Connolly M, Nye P, Lyagoshina T, Besse C: Tuberculosis in Siberia: 2. Diagnosis, chemoprophylaxis and treatment. Tubercle and Lung Disease (1966) 77:297-301.
23. Weis SE, Slocum PC, Blais FX, King B, Nunn M, Matney GB, Comez E, Foresman BH: The effect of directly observed therapy on the rates of drug resistance and relapse in tuberculosis. New England Journal of Medicine (1994) 330:1179-1184.
24. Schluger N, Ciotoli C, Cohen D, Johnson H, Rom WN: Comprehensive tuberculosis control for patients at high risk for noncompliance. American Journal of Respiratory and Critical Care Medicine (1995) 151:1486-1490.
25. Chaulk CP, Moorerice K, Rizzo R, Chaisson RE: Eleven years of community-based directly observed therapy for tuberculosis. Journal of the American Medical Association (1995) 274:945-951.
26. Zhao FZ, Murray C, Spinaci S, Styblo K, Broekmans J, Zou JQ, Dai YS, Chi YH, Du X, Cao JP, Chen YL, Li LM, Liu CJ, Liu HQ, Lu Q, Tang DR, Wang PF, Wang ZH, Wu PE, Zhang FD, Zhang FS, Zhu GL: Results of directly observed short-course chemotherapy in 112 842 Chinese patients with smear-positive tuberculosis. Lancet (1996) 347:358-362.